Impact of Endometrial cavity Fluid Aspiration before embryo transfer

Impact of Endometrial cavity Fluid Aspiration Prior to Embryo Transfer on Pregnancy Outcomes in IVF Patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250521065832N1

Enrollment

Registered

2025-12-27

Start date

2025-12-22

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cavity fluid before embryo transfer.

Interventions

Intervention group: There are patients undergoing frozen embryo transfer cycles who initially receive medication for endometrial preparation, and on the day-12 ultrasound assessment of endometrial thi

Eligibility

Sex/Gender

Female

Age

18 Years to 44 Years

Inclusion criteria

Inclusion criteria: aged 18–44 years, with a body mass index (BMI) ranging from 18 to 25 kg/m² and endometrial cavity fluid (ECF) on transvaginal ultrasound before embryo transfer

Exclusion criteria

Exclusion criteria: Women were excluded if they had identifiable endometrial or uterine pathology, including endometrial polyps, uterine fibroids, adenomyosis, hydrosalpinx, stage III–IV endometriosis, congenital uterine anomalies and recurrent pregnancy loss.

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy rate. Timepoint: 14 days after embryo transfer. Method of measurement: Beta-HCG test.;Clinical pregnancy rate. Timepoint: 2 weeks after positive pregnancy test. Method of measurement: Transvaginal Ultrasound.;Ongoing pregnancy rate. Timepoint: 10 weeks after positive pregnancy test. Method of measurement: Transvaginal Ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHatav Ghsemi Tehrani

Esfahan University of Medical Sciences

tehtrani@med.mui.ac.ir+98 31 3236 7002

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026